An Open-label Safety Study of Dipraglurant (ADX48621) in Patients with Parkinson's Disease Receiving Levodopa-based Therapy With or Without Concomitant Dopaminergic Medications

March 14, 2022
https://clinicaltrials.gov/ct2/show/NCT05116813
Parkinson Disease
Principal Investigator: Peter A Le Witt, MD
Parkinson Disease
Open
248-661-7257